Skip to main content
Top
Published in: Osteoporosis International 1/2010

01-01-2010 | Case Report

Raloxifene enhances spontaneous microaggregation of platelets through upregulation of p44/p42 MAP kinase: a case report

Authors: H. Tokuda, A. Harada, S. Adachi, R. Matsushima-Nishiwaki, H. Natsume, C. Minamitani, J. Mizutani, T. Otsuka, O. Kozawa

Published in: Osteoporosis International | Issue 1/2010

Login to get access

Abstract

Summary

A 60-year-old postmenopausal woman diagnosed as primary osteoporosis began to take raloxifene. The spontaneous microaggregates of platelets induced by shear stress were accelerated after the treatment, concomitant with the significant upregulation of p44/p42 mitogen-activated protein (MAP) kinase induced by adenosine diphosphate (ADP). After the cessation of raloxifene, the spontaneous microaggregates of platelets and the acceleration of ADP-induced p44/p42 MAP kinase phosphorylation was diminished. We concluded that raloxifene caused platelet hyperaggregability to shear stress and p44/p42 MAP kinase was involved in the pathological state.

Introduction

A 60-year-old postmenopausal woman suffering from severe lumbago was diagnosed as primary osteoporosis with combined vertebral fractures. After the acute phase, she began to take 60 mg daily of oral raloxifene. The spontaneous microaggregates of platelets induced by shear stress were accelerated significantly after 8 weeks from the beginning of raloxifene treatment and observed at 12 weeks.

Results

The platelet aggregation induced by ADP was little changed; however, low doses (0.3 and 1 μM) of ADP significantly induced the phosphorylation of p44/p42 MAP kinase in the platelets obtained at 12 weeks. Although there were few subjective complaints except for paroxysmal headache, the medication was stopped with her consent to avoid any adverse effects. The spontaneous microaggregates of platelets gradually decreased after the cessation of medication. At 12 weeks after the cessation, the phosphorylation of p44/p42 MAP kinase induced by low doses of ADP was no more observed.

Conclusion

These results strongly suggest that raloxifene caused platelet hyperaggregability to shear stress and subclinical thrombus formation in this case and that p44/p42 MAP kinase was involved in the pathological state.
Literature
1.
go back to reference Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nichelsen T, Gerant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple outcomes of raloxifene evaluation (MORE) investigators. JAMA 282:637–645CrossRefPubMed Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nichelsen T, Gerant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple outcomes of raloxifene evaluation (MORE) investigators. JAMA 282:637–645CrossRefPubMed
2.
go back to reference Peverill RE (2003) Hormone therapy and venous thromboembolism. Best Pract Res Clin Endocrinol Metab 17:149–164CrossRefPubMed Peverill RE (2003) Hormone therapy and venous thromboembolism. Best Pract Res Clin Endocrinol Metab 17:149–164CrossRefPubMed
3.
go back to reference Minamitani C, Takai S, Matsushima-Nishiwaki R, Hanai Y, Otsuka T, Kozawa O, Tokuda H (2008) Raloxifene-induced acceleration of platelet aggregation. Inter Med 47:1523–1528CrossRef Minamitani C, Takai S, Matsushima-Nishiwaki R, Hanai Y, Otsuka T, Kozawa O, Tokuda H (2008) Raloxifene-induced acceleration of platelet aggregation. Inter Med 47:1523–1528CrossRef
4.
5.
go back to reference Kahner BN, Shankar H, Murugappan S, Prasad GL, Kunapuli P (2006) Nucleotide receptor signaling in platelets. J Thromb Haemostasis 4:2317–2326CrossRef Kahner BN, Shankar H, Murugappan S, Prasad GL, Kunapuli P (2006) Nucleotide receptor signaling in platelets. J Thromb Haemostasis 4:2317–2326CrossRef
6.
go back to reference Kowalska MA, Ratajczak MZ, Majka M, Jin J, Kunapuli S, Brass L, Poncz M (2000) Stromal cell-derived factor-1andmacrophage-derived chemokine: 2 factor-1andmacrophage-derived chemokine: 2 chemokines that activate platelets. Blood 96:50–57PubMed Kowalska MA, Ratajczak MZ, Majka M, Jin J, Kunapuli S, Brass L, Poncz M (2000) Stromal cell-derived factor-1andmacrophage-derived chemokine: 2 factor-1andmacrophage-derived chemokine: 2 chemokines that activate platelets. Blood 96:50–57PubMed
7.
go back to reference Garcia A, Shankar H, Murugappan S, Kim S, Kumpuli SP (2007) Regulation and functional consequences of ADP receptor-mediated ERK2 activation in platelets. Biochem J 404:299–308CrossRefPubMed Garcia A, Shankar H, Murugappan S, Kim S, Kumpuli SP (2007) Regulation and functional consequences of ADP receptor-mediated ERK2 activation in platelets. Biochem J 404:299–308CrossRefPubMed
8.
go back to reference Fabre JE, Nguyen M, Latour A, Keifer JA, Audoly LP, Coffman TM, Koller BH (1999) Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 5:1199–1202CrossRefPubMed Fabre JE, Nguyen M, Latour A, Keifer JA, Audoly LP, Coffman TM, Koller BH (1999) Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 5:1199–1202CrossRefPubMed
9.
go back to reference Dorsam RT, Kunapuli SP (2004) Central role of the P2Y12 receptor in platelet aggregation. J Clin Invest 113:334–345 Dorsam RT, Kunapuli SP (2004) Central role of the P2Y12 receptor in platelet aggregation. J Clin Invest 113:334–345
10.
go back to reference Matsuno H, Tokuda H, Ishisaki A, Zhou Y, Kitajima Y, Kozawa O (2005) P2Y12 receptors play a significant role in the development of platelet microaggregation in patients with diabetes. J Clin Endocrinol Metab 90:920–927CrossRefPubMed Matsuno H, Tokuda H, Ishisaki A, Zhou Y, Kitajima Y, Kozawa O (2005) P2Y12 receptors play a significant role in the development of platelet microaggregation in patients with diabetes. J Clin Endocrinol Metab 90:920–927CrossRefPubMed
11.
go back to reference Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-Hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H, Osteoporosis diagnostic criteria review committee: Japanese Society for Bone and Mineral Research (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331–337CrossRefPubMed Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-Hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H, Osteoporosis diagnostic criteria review committee: Japanese Society for Bone and Mineral Research (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331–337CrossRefPubMed
12.
go back to reference Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, Kume S (1994) Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 218:284–294CrossRefPubMed Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, Kume S (1994) Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 218:284–294CrossRefPubMed
13.
go back to reference Naik UP, Naik MU (2003) Association of CIB with GPIIb/IIIa during outside-in signaling is required for platelet spreading on fibrinogen. Blood 102:1335–1362 Naik UP, Naik MU (2003) Association of CIB with GPIIb/IIIa during outside-in signaling is required for platelet spreading on fibrinogen. Blood 102:1335–1362
Metadata
Title
Raloxifene enhances spontaneous microaggregation of platelets through upregulation of p44/p42 MAP kinase: a case report
Authors
H. Tokuda
A. Harada
S. Adachi
R. Matsushima-Nishiwaki
H. Natsume
C. Minamitani
J. Mizutani
T. Otsuka
O. Kozawa
Publication date
01-01-2010
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 1/2010
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-009-0927-9

Other articles of this Issue 1/2010

Osteoporosis International 1/2010 Go to the issue